INSULET CORP (PODD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PODD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PODD | Board Chair; Special Limited Partner, Warburg Pincus | 66 | ["Special Limited Partner of Warburg Pincus since January 2016","Joined Warburg Pincus in 1988","Led firm’s Healthcare Group from 2008 to 2015","Managing Director and member of the firm’s Executive Management Group","Director of Royalty Pharma","Director of Stanford Health Care","Trustee of Stanford University","Trustee and chair of the Investment Committee of Mount Holyoke College","BA in English from Mount Holyoke College","MBA from the Stanford Graduate School of Business","Chair"] | ["Talent and Compensation (Chair)","Nominating","Governance and Risk","Talent and Compensation","Nominating, Governance and Risk Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Elizabeth Weatherman has served on our Board of Directors since February 2022 and as our Board Chair since December 2025. She has been a Special Limited Partner of Warburg Pincus since January 2016. Ms. Weatherman joined Warburg Pincus in 1988 and led the firm s Healthcare Group from 2008 to 2015, serving as a Managing Director and a member of the firm s Executive Management Group. Ms. Weatherman serves as a director of Royalty Pharma, as a director of Stanford Health Care, as a trustee of Stanford University and as a trustee and chair of the Investment Committee of Mount Holyoke College. Ms. Weatherman earned a BA in English from Mount Holyoke College and an MBA from the Stanford Graduate School of Business. With her extensive healthcare investment knowledge as well as her experience on the boards of other public medical device companies, Ms. Weatherman brings strong strategic, industry and governance perspectives.